CHIRON CAPITAL MANAGEMENT, LLC

Position in NVO — Novo Nordisk A S

CIK 1830922 TALLAHASSEE, FL

Position in NVO

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$619,912

+$203,094 QoQ

Shares Held

12,931

+14.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.62%

of 13F equity value

Holder Rank

#646

of 1,348 holders

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHIRON CAPITAL MANAGEMENT, LLC holds $16,063,883 across 6 Drug Manufacturers - General names. NVO ranks #5 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	206,970	$11,925,611
2	PFE	Pfizer Inc	67,214	$1,618,513
3	GILD	Gilead Sciences, Inc.	8,080	$1,020,827
4	SNY	Sanofi	15,102	$644,251
5	NVO	Novo Nordisk A S This page	12,931	$619,912
6	MRK	Merck & Co., Inc.	1,827	$234,769

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$619,912	12,931	+14.0%	Shares	Sole	2026-07-21
2026-03-31	$416,818	11,342	+212.6%	Shares	Sole	2026-04-21
2025-09-30	$201,317	3,628	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.